Federated Hermes’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-26,467
| Closed | -$52.7K | – | 2168 |
|
|
2025
Q2 | $52.7K | Buy |
26,467
+2,038
| +8% | +$3.73K | ﹤0.01% | 1634 |
|
|
2025
Q1 | $35.4K | Buy |
24,429
+13,728
| +128% | +$25.4K | ﹤0.01% | 1667 |
|
|
2024
Q4 | $22.2K | Buy |
10,701
+5,425
| +103% | +$10.2K | ﹤0.01% | 1762 |
|
|
2024
Q3 | $9.29K | Buy |
5,276
+3,926
| +291% | +$10.1K | ﹤0.01% | 1814 |
|
|
2024
Q2 | $19.5K | Sell |
1,350
-368
| -21% | -$5.06K | ﹤0.01% | 1720 |
|
|
2024
Q1 | $28.6K | Sell |
1,718
-3
| -0.2% | -$48 | ﹤0.01% | 1684 |
|
|
2023
Q4 | $27.6K | Sell |
1,721
-392
| -19% | -$5.21K | ﹤0.01% | 1717 |
|
|
2023
Q3 | $28.4K | Buy |
2,113
+943
| +81% | +$13.3K | ﹤0.01% | 1741 |
|
|
2023
Q2 | $20.1K | Sell |
1,170
-1,025
| -47% | -$15.9K | ﹤0.01% | 1774 |
|
|
2023
Q1 | $36.3K | Sell |
2,195
-355
| -14% | -$5.68K | ﹤0.01% | 1764 |
|
|
2022
Q4 | $42.7K | Buy |
+2,550
| New | +$46K | ﹤0.01% | 1734 |
|
Federated Hermes's HLVX Position: Q3 2025 in Review
Federated Hermes sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 26,467 shares — an estimated $52.7K sold.
Federated Hermes first reported a position in HLVX in Q4 2022 and held it in 11 quarters. The position peaked at $52.7K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Federated Hermes reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Federated Hermes sold 26,467 HilleVax shares in Q3 2025, an estimated $52.7K.
- Federated Hermes first reported a position in HilleVax in Q4 2022 and held it in 11 quarters.
- Federated Hermes's HilleVax position peaked at $52.7K in Q2 2025.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.